Q4 2024
Released Feb 18, 2025, after the close
10-K filed Feb 19, 2025, 50 days after period end · 0001653477-25-000015
Q4 2024 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$135.60M$135.60M derivedno prior Q4 2023 on file−59.4% vs Q3 2024
Net Income$16.60M$16.60M derivedN/M vs Q4 2023N/M vs Q3 2024
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$110,300,000+238.3%
Operating Incomederived$137,500,000+55.9%
Operating Cash Flowderived$64,500,000+39.6%
Free Cash Flowderived$39,600,000+132.9%
Margins · derived
Gross margin81.3%
Operating margin101.4%
Net margin12.2%
What the release said
The release
Same quarter
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures |
|---|---|---|---|---|
| Revenue | $135.60M | — | $383.60M | $336.00M |
| Net Income | $16.60M | -$116.80M | $15.60M | $29.30M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ingevity Corp · CIK 1653477 · Engraved from SEC EDGAR